South Korean scientists have cloned the world's first mature embryonic stem-cell line, in what is seen as a breakthrough toward developing new methods of treating a wide range of degenerative ailments, a US science group reported.
But the controversial experiment announced on Wednesday is also likely to raise new concerns about cloning human beings.
"Because these cells carry the nuclear genome of the individual, after differentiation they could be expected to be transplanted without immune rejection for treatment of degenerative disorders," said Woo Suk-hwang of Seoul National University, the lead researcher on the project.
"Our approach opens the door for the use of these specially developed cells in transplantation medicine," he said in a statement released by the American Association for the Advancement of Science.
A summary of the study made public by the association said Woo and a group of other South Korean scientists were able to produce versatile and "pluripotent" stem cells by taking part of a non-reproductive cell from women and transplanting it into the women's eggs.
Blastocysts, or precursors to fetuses, produced through this transfer created a cell mass that was used to harvest well-developed embryonic stem cells, according to the document.
The method was used to develop a whole human embryonic stem-cell line, using a total of 242 eggs collected from 16 women, all unpaid volunteers.
These eggs made it possible to grow a total of 30 blastocysts and obtain 20 suitable inner-cell masses, the report said.
The resulting stem cells differentiated into all the main tissue types that appear in the early stages of human development, the researchers said.
When transplanted into mice, the stem cells differentiated into still more specific cell types, offering further proof of pluripotency, they noted.
The key to their success, the researchers believe, lay in using extremely fresh donor eggs, following stringent timing protocols and a special method of extracting DNA from eggs.
The approach has been previously used to generate cells from mice, but up to now, nobody had been successful in applying it to humans, US scientists said.
Experts said the South Korean experiment may represent a major step toward developing new cures for severe and chronic ailments such as diabetes, osteoarthritis, Parkinson's disease and others.
WAITING GAME: The US has so far only offered a ‘best rate tariff,’ which officials assume is about 15 percent, the same as Japan, a person familiar with the matter said Taiwan and the US have completed “technical consultations” regarding tariffs and a finalized rate is expected to be released soon, Executive Yuan spokeswoman Michelle Lee (李慧芝) told a news conference yesterday, as a 90-day pause on US President Donald Trump’s “reciprocal” tariffs is set to expire today. The two countries have reached a “certain degree of consensus” on issues such as tariffs, nontariff trade barriers, trade facilitation, supply chain resilience and economic security, Lee said. They also discussed opportunities for cooperation, investment and procurement, she said. A joint statement is still being negotiated and would be released once the US government has made
Authorities have detained three former Taiwan Semiconductor Manufacturing Co (TMSC, 台積電) employees on suspicion of compromising classified technology used in making 2-nanometer chips, the Taiwan High Prosecutors’ Office said yesterday. Prosecutors are holding a former TSMC engineer surnamed Chen (陳) and two recently sacked TSMC engineers, including one person surnamed Wu (吳) in detention with restricted communication, following an investigation launched on July 25, a statement said. The announcement came a day after Nikkei Asia reported on the technology theft in an exclusive story, saying TSMC had fired two workers for contravening data rules on advanced chipmaking technology. Two-nanometer wafers are the most
NEW GEAR: On top of the new Tien Kung IV air defense missiles, the military is expected to place orders for a new combat vehicle next year for delivery in 2028 Mass production of Tien Kung IV (Sky Bow IV) missiles is expected to start next year, with plans to order 122 pods, the Ministry of National Defense’s (MND) latest list of regulated military material showed. The document said that the armed forces would obtain 46 pods of the air defense missiles next year and 76 pods the year after that. The Tien Kung IV is designed to intercept cruise missiles and ballistic missiles to an altitude of 70km, compared with the 60km maximum altitude achieved by the Missile Segment Enhancement variant of PAC-3 systems. A defense source said yesterday that the number of
Taiwanese exports to the US are to be subject to a 20 percent tariff starting on Thursday next week, according to an executive order signed by US President Donald Trump yesterday. The 20 percent levy was the same as the tariffs imposed on Vietnam, Sri Lanka and Bangladesh by Trump. It was higher than the tariffs imposed on Japan, South Korea and the EU (15 percent), as well as those on the Philippines (19 percent). A Taiwan official with knowledge of the matter said it is a "phased" tariff rate, and negotiations would continue. "Once negotiations conclude, Taiwan will obtain a better
RSS